Skip to main content

Closing Bell: Biosyent Inc down on Friday (RX)

Automated Summaries - The Globe and Mail - Fri Aug 2, 4:01PM CDT

Biosyent Inc opened trading today at $10.21 and closed at $10.09. prices ranged from $9.90 to $10.21.

Share prices decreased -1.08% from the previous day's close of $10.20.

During the day across North America, the TSX Composite closed -2.18% at 22227.63, the S&P 500 closed -1.37% at 5446.68, the Dow Jones Industrial Average closed -1.21% at 40347.97 and the Nasdaq Composite closed -2.30% at 17194.15.

Biosyent Inc has listed on the Toronto Venture Exchange (TSX-V) under the ticker RX.

A total of 9,710 shares was traded during the last trading day, with total trades of 17. On average, Biosyent Inc has traded 8,142 shares in the last five days and 6,646 year-to-date.

Trading across the entire TSX-V saw 741 price advancers against 4,512 declines and 69 unchanged.

During the prior 52 weeks, RX.VN has traded as high as $10.75 (June 21,2024) and low as $7.55 (August 08,2023). Moreover, the shares have raised 32.76 percent in the last 12 months, while they have advanced 9.44% since the start of 2024.

It announced a 0.04 dividend on May 16/24, with an May 31/24 ex-date and June 15/24 pay day.

Following today's trading, Biosyent Inc has a market capitalization of $118.16 million on a float of 11,584 shares outstanding. Its annual EPS is $0.58.

Biosyent Inc is a TSX Drug Specialty & Generic company headquartered in Mississauga, CAN.

Biosyent Inc is holding an average recommendation of "Moderate Buy" from 1.00 analysts according to Zacks. From those 1 analysts, 1 have buy ratings.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..